Stevanato Group is set to commence construction on its new $145m manufacturing facility in Fishers, Indiana in the US, this month.

Planned to be competed in 2023, the site will provide an additional supply source for the firm’s mission critical products while allowing it to better serve North America pharmaceutical customers.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Expected to be up to 370,000ft2, the new facility will also support the expansion and production of Stevanato’s EZ-Fill solutions, pre-sterilised drug containment systems for pharmaceutical use.

The plant will comprise production lines featuring advanced process technologies to produce EZ-Fill syringes and vials.

Stevanato said it plans to use the new facility as a centre for after-sales support to serve its North American engineering customers.

See Also:

The facility will also allow the firm to offer technical support as well as maintenance for visual inspection, assembly and packaging equipment.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Stevanato Group CEO Franco Moro said: “We are thrilled to begin construction on our new US hub, and expand our presence in one of the fastest growing markets where we see increasing demand.

“We believe this will allow us to further enhance our services to our valued North America customers and underscores our desire to ensure supply chain security, just in time delivery and reliable sourcing in terms of surge capacity.”

The facility is expected to create more than 230 jobs in production, engineering and maintenance, as well as other corporate support positions by the end of 2025.

Stevanato said that the plant would be part of a new pharmaceutical and life sciences park in Fishers.

———————————————————————————————————————-
The facility is expected to create more than 230 jobs. Credit: Giomar Arang/Pixabay.